Search Results 971-980 of 17262 for Paroxetine

  1. Pro-Active Identification of Risk factors for Complex Behavioral Patients - Mayo Clinic

    Our study objective is to examine the implementation and effectiveness of an integrated behavioral safety delivery platform (ProActive) in clinical practice.

  2. A Study to Evaluate Pomalidomide to Treat Bleeding in Hereditary Hemorrhagic Telangiectasia (HHT) - Mayo Clinic

    placebo in patients with hereditary hemorrhagic telangiectasia (HHT) with moderate-to-severe epistaxis who require parenteral iron infusions or blood ...

  3. Mayo Clinic

    Parking for patients and visitors is available in an underground parking ramp across from the Mayo Clinic Building. The parking ramp has direct access to ...

  4. Gastroenterology and Hepatology - Clinical trials

    Rochester, Minn. The purpose of this study is to create a registry of obese patients who have been phenotyped to understand the heterogeneity of obesity. Celiac ...

  5. Clinical trials - Oncology (Medical)

    Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.

  6. Cardiovascular Medicine - Clinical trials

    The CASCADE Familial Hypercholesterolemia Registry will track therapy, clinical outcomes, and patient-reported outcomes over time aiming to increase ...

  7. Brain tumor - Doctors and departments - Mayo Clinic

    Learn about our team of brain tumor doctors and surgeons who are researching new ways of diagnosing and treating this condition.

  8. An Expanded Access Study of Iniparib Combined with Gemcitabine and Carboplatin for the Treatment of Breast Cancer - Mayo Clinic

    The purpose of this study is to offer pre-approval drug access of iniparib combined with gemcitabine and carboplatin, in order to provide potential clinical ...

  9. CONVERGE Post-Approval Study (PAS) - Mayo Clinic

    About this study. The primary objective of CONVERGE PAS is to evaluate clinical outcomes (peri-procedural and long-term) in a cohort of patients treated ...

  10. Pilot Clinical Trial Evaluating the Utility of Minocycline as an Agent to Decrease Chemotherapy-Induced Peripheral Neuropathy (CIPN) and Paclitaxel-Induced Acute Pain Syndrome (P-APS): A Randomized Placebo-Controlled, Double Blind Trial - Mayo Clinic

    Pilot Clinical Trial Evaluating the Utility of Minocycline as an Agent to Decrease Chemotherapy-Induced Peripheral Neuropathy (CIPN) and Paclitaxel-Induced ...